Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04842110
Other study ID # D0000000151
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 24, 2019
Est. completion date December 21, 2019

Study information

Verified date April 2021
Source Dominion Aesthetic Technologies, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a marketing study intended to provide additional data for marketing purposes for the eon™ FR is FDA 510(k) which has been cleared for non-invasive lipolysis of the abdomen to achieve disruption of adipocyte cells intended for non-invasive aesthetic use to achieve a desired aesthetic effect. This device is intended for individuals with a Body Mass Index (BMI) of 30 kg/m2 or less.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date December 21, 2019
Est. primary completion date December 21, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Subject is a healthy male or female > 18 years or older seeking treatment for unwanted fat in the abdomen. - Subject must be able to read, understand and sign the Informed Consent Form (ICF) in English. - Subject has sufficient thickness (= 25 mm) of adipose tissue on the abdomen area. - Study subjects must agree to maintain their current diet and weight (not gaining or losing greater than ±5 lbs. - Subject must be willing and able to adhere to the treatment and follow-up visit schedule. - Subject must be willing to have limited sun exposure for the duration of the study, including the follow-up period. - Subject is willing to have photographs and ultrasound measurements taken of the treated area, which will be de-identified in evaluations and may be used in presentations and/or publications. - Female subjects must be using medically acceptable form of birth control during the entire course of the study or may be post-menopausal, surgically sterilized. Exclusion Criteria: - Aesthetic fat reduction procedure in the treatment area within the previous year. - Pregnant in the last 3 months, intending to become pregnant, postpartum or nursing in last 6 months - Unstable weight within the last 6 months (+ or - 3% weight change in the prior six months) - Subject has an infection, dermatitis or a rash in the treatment area. - Subject has tattoos or jewelry in the treatment area or within the treatment area site or photography frame. - Subject has a history of keloid scarring, hypertrophic scarring or of abnormal wound healing. - Subject has a history of immunosuppression/immune deficiency disorders or currently using immunosuppressive medications. - Subject has a history of a known bleeding disorder. - Subject has a known photosensitivity to the study laser wavelength, history of ingesting medications known to induce photosensitivity, or history of seizure disorders due to light. - Subject has known collagen, vascular disease or scleroderma. - Subject has undergone a surgery or procedure in the treatment area within 6 months of treatment, which is still healing. - Subject suffers from significant concurrent illness, such as insulin-dependent diabetes, peripheral vascular disease or peripheral neuropathy. - Subject is undergoing systemic chemotherapy for the treatment of cancer. - Subject is using gold therapy for disorders such as rheumatologic disease or lupus. - Subject has participated in a study of another device or drug within three months prior to enrollment or during the study. - As per the investigator's discretion, the subject has any physical or mental condition which might make it unsafe for the subject to participate in this study. - Subject has ongoing use of steroids or secondary rheumatoid drugs. - Subject is actively taking psychotropic medications.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Experimental: eonTM FR 1064 nm device
The subject treatment area - abdomen, was treated with the 1064 nm wavelength laser.

Locations

Country Name City State
United States Fiala Aesthetics Altamonte Springs Florida

Sponsors (1)

Lead Sponsor Collaborator
Dominion Aesthetic Technologies, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Photographic Evaluations as a Measure of Effectiveness Photographs of the treatment area will be obtained at baseline and 12 weeks post treatment and be evaluated by blinded independent readers to correctly identify pre-treatment (baseline) photographs compared to 12 weeks post treatment photographs in order to determine effectiveness of device. 12 Weeks
Secondary Change in Adipose Layer Thickness Ultrasound measurements of adipose layer thickness will be collected at baseline and 12 weeks after procedure to evaluate changes between both. 12 weeks
Secondary Subject Satisfaction Subject Questionnaires will be completed by subjects at the end of study to determine the subject satisfaction with procedure. 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04940962 - Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion N/A
Completed NCT02194504 - The Belly Fat Study: Nutritional Intervention to Improve Metabolic Health in Subjects With Increased Abdominal Adiposity N/A
Completed NCT00374218 - Effect of Replacing HFCS With Sucromalt in Subjects With Raised Waist Circumference Phase 2
Completed NCT00520858 - Effects of Exercise Modality on Abdominal Obesity and Health Risk Factors in Older Men and Women N/A
Recruiting NCT03212391 - WAVE Study- Walking and Aging in VErona Study N/A
Completed NCT03898518 - The Effects of a Jump Rope Exercise Program on Body Composition and Self-efficacy in Obese Adolescent Girls N/A
Recruiting NCT04136717 - Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery N/A
Completed NCT05413954 - To Evaluate the Health Effect of Particular Fatty Acids Profiles From Eggs N/A
Recruiting NCT05062954 - Effects of a Polyphenol-rich Cranberry Extract on Cardiometabolic and Neurocognitive Health N/A
Completed NCT01472666 - Dairy Lipids, Proteins, and the Metabolic Syndrome - "DairyHealth" N/A
Completed NCT00990457 - Evaluating the Effects Two Diets Combined With Exercise in Persons With Abdominal Obesity (The SHAPE5 Study) Phase 3
Completed NCT05685017 - Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents
Completed NCT03773900 - Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers N/A
Completed NCT04635332 - Food Literacy and Physical Activity Intervention to Optimize Metabolic Health Among Women in Urban Uganda N/A
Completed NCT00739180 - Physical Activity in Youth: Implications for Reversing Risk Factors for Type 2 Diabetes N/A
Completed NCT00664729 - Diet, Exercise, Metabolism, and Obesity in Older Women N/A
Completed NCT03389425 - Application of the SIMPLE Program for Weight Loss at Pathways to Housing: A Feasibility Study N/A
Completed NCT05900843 - Weight Abnormalities With Diet and Exercise Frequency in Egyptian Children With Cerebral Palsy
Not yet recruiting NCT06376955 - High Intensity Interval Versus Focused Ultrasound on Insulin Resistance in Diabetics With Abdominal Obesity N/A
Recruiting NCT05879692 - Response of Irritable Bowel Syndrome to Abdominal Fat Reduction N/A